Impax Laboratories Inc (NASDAQ:IPXL)

47.06
BATS BZX Real-Time Price
As of 10:30am ET
 +0.40 / +0.86%
Today’s Change
22.12
Today|||52-Week Range
52.10
+48.55%
Year-to-Date

Today’s Trading

Previous close46.66
Today’s open46.61
Day’s range46.12 - 49.97
Volume156,824
Average volume (3 months)657,288
Market cap$3.4B
Dividend yield--
Data as of 10:15am ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+10.19%
Earnings growth (next 5 years)+25.66%
Revenue growth (last year)+16.53%
P/E ratio57.3
Price/Sales3.62
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-1.28-3.24%
ASPXAuspex Pharmaceutica...-0.02-0.01%
ACADACADIA Pharmaceutica...-0.52-1.46%
CLVSClovis Oncology Inc-1.59-1.90%
Data as of 10:30am ET, 04/28/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)$0.17
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers